Deutsche Bank’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
SFM
BIT
GAI
AIA
Deutsche Bank's RPRX Position: Q4 2016 in Review
Deutsche Bank sold out of Repros Therapeutics Inc. (RPRX) in Q4 2016, closing a stake of 2,446 shares — an estimated $5K sold.
Deutsche Bank first reported a position in RPRX in Q2 2013 and held it in 14 quarters. The position peaked at $1.74M in Q2 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.
- Deutsche Bank reported no remaining Repros Therapeutics Inc. position as of Q4 2016 after selling out during the quarter.
- Deutsche Bank sold 2,446 Repros Therapeutics Inc. shares in Q4 2016, an estimated $5K.
- Deutsche Bank first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 14 quarters.
- Deutsche Bank's Repros Therapeutics Inc. position peaked at $1.74M in Q2 2013.
- 43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.
Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.